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Background: Higher aluminum (Al) content in infant formula and its effects on neonatal brain development are a
cause for concern. This study aimed to evaluate the distribution and concentration of Al in neonatal rat brain
following Al treatment, and oxidative stress in brain tissues induced by Al overload.
Methods: Postnatal day 3 (PND 3) rat pups (n =46) received intraperitoneal injection of aluminum chloride (AlCl3),
at dosages of 0, 7, and 35 mg/kg body wt (control, low Al (LA), and high Al (HA), respectively), over 14 d.
Results: Aluminum concentrations were significantly higher in the hippocampus (751.0 ± 225.8 ng/g v.s. 294.9 ±
180.8 ng/g; p < 0.05), diencephalon (79.6 ± 20.7 ng/g v.s. 20.4 ± 9.6 ng/g; p< 0.05), and cerebellum (144.8 ± 36.2
ng/g v.s. 83.1 ± 15.2 ng/g; p< 0.05) in the HA group compared to the control. The hippocampus, diencephalon,
cerebellum, and brain stem of HA animals displayed significantly higher levels of lipid peroxidative products (TBARS)
than the same regions in the controls. However, the average superoxide dismutase (SOD) activities in the cerebral
cortex, hippocampus, cerebellum, and brain stem were lower in the HA group compared to the control. The HA
animals demonstrated increased catalase activity in the diencephalon, and increased glutathione peroxidase (GPx)
activity in the cerebral cortex, hippocampus, cerebellum, and brain stem, compared to controls.
Conclusion: Aluminum overload increases oxidative stress (H2O2) in the hippocampus, diencephalon, cerebellum,
and brain stem in neonatal rats.
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Increasing evidence has demonstrated that oxidative stress
is the primary cause of pathogenesis in inflammatory, par-
tial ischemia, metabolic, and denatured cranial nerve dis-
ease [1]. Brain tissues are highly susceptible to oxidative
damage, probably because of high oxygen consumption
rate (20%), the presence of abundant polyunsaturated fatty
acids in cell membranes, high iron (Fe) content, and low
anti-oxidative enzyme activities [2]. Although aluminum
(Al) is a relatively low redox mineral, it can induce oxida-
tive damage through multiple mechanisms. It can bind to
negatively charged brain phospholipids, which contain
polyunsaturated fatty acids and are easily attacked by react-
ive oxygen species (ROS) such as O2
˙-, H2O2, OH
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reproduction in any medium, provided the orOH- [3]. Aluminum can also stimulate iron-initiated lipid
peroxidation in the Fenton reaction, which causes ROS
production and Fe3+ formation. Superoxide (O2
˙-) is neutra-
lized by Al3+ to form an Al-O2
˙- complex, which increases
the oxidative capacity of O2
˙- [4].
Reactive oxygen species may also cause cellular damage,
by oxidizing amino acid residues on proteins, forming pro-
tein carbonyls [5]. The study of Kowalczyk et al. showed
that three months’ administration of aluminum chloride in
drinking water at a dose of 80 mg/l significantly elevated
protein carbonyl groups concentration in erythrocytes
hemolysate [6]. Lesions existed in the brains of Alzheimer’s
disease (AD) patients are typically associated with attacks
by free radicals, and Al is shown to have catalytic activity
to produce free radicals. In addition, beta-amyloid protein
in the brain of AD patients is aggregated and induces more
free radicals production [7].
Several studies have shown that oxidative stress
induced by Al modifies the peroxidation of lipids and
the activities of anti-oxidative enzymes. Julka and Gilld. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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brain tissues of adult Wistar rats following administra-
tion of 10 mg/d Al (aluminum lactate) for 4 wk. Oral ad-
ministration of Al acetate (4000 mg Al /kg body wt and
6000 mg Al /kg body wt) for 8 wk resulted in higher
lipid peroxidative products (thiobarbituric acid reactive
substances, or TBARS) in mouse brain tissue lysates [9].
In the study of Katyal et al, aluminum treatment
increased hyperoxidation of cerebral proteins [10]. A dif-
ferent study, however, observed that lower Al3+ (12.5
μmol/L) inhibited oxidation of mouse cerebellar tissue
proteins, while higher Al3+ (25 μmol/L and 50 μmol/L)
increased oxidation of the proteins [11]. Aluminum can,
therefore, induce protective effects against oxidative
stress and also cause damaging effects through oxidative
stress.
The main route of Al excretion is the urine; therefore,
subjects with kidney malfunction or immature kidney,
such as nephropathy patients or neonates, might experi-
ence toxic accumulation of Al in the body [12]. Infant
formula is the primary food source for bottle-fed neo-
nates. The study of Yuan et al reviewed several other
studies and reported that most commercial infant for-
mulas contained higher Al (6.5 μM to 87 μM) than
human breast milk (0.2 μM to 1.7 μM) [12]. Infants dis-
play rapid growth and their brain-blood-barrier, detoxifi-
cation system (liver), and excretory system (kidney) are
not well-developed [13,14]. Aluminum can cross the
blood-brain barrier and accumulate in glial and neural
cells [15]. Thus, high intake of Al-containing formula
might cause accumulation of Al in the neonatal brain,
interfering with appropriate development.
In previous studies, exposure to excess dietary Al dur-
ing gestation and lactation periods had no toxic effects
on the mother, but resulted in persistent neurobeha-
vioral deficits in the pups, such as defects in the sensory
motor reflexes, locomotor activity, learning capability,
and cognitive behavior [16,17]. These behavioral studies,
therefore, suggested that Al exposure might cause devel-
opmental changes in neonatal brain. Until recently, a
marker with which to effectively detect neonatal brain
development was lacking. The group’s previous study
with Al treatment in neonatal rat hippocampal neurons
at concentrations of 37 μM and 74 μM for 14 days sig-
nificantly reduced NMDAR (N-methyl-D-aspartate re-
ceptor) expression which was used as a marker of brain
development. This suggested that Al exposure might in-
fluence the development of hippocampal neurons in
neonatal rats [12].
In previous studies on adult animals, Al induced the
production of ROS and caused oxidative damage in the
brain [3-11]. Neonatal animal studies also identified that
Al exposure during gestation and lactation periods
induced brain developmental deficits in pups [12,16,17].Thus, the hypothesis of the present study was that ROS
might be the cause of developmental damage in the neo-
natal brain following Al administration. In order to ef-
fectively induce an Al overload state in animals, the
experiments, therefore, involved intraperitoneal injection
of equivalent amounts of Al (AlCl3) into PND 3 neonatal
rats during a 14 d lactation period. The deposition of Al,
oxidative stress related enzyme activities as well as thio-
barbituric acid reactive substances (TBARS) in func-
tional areas of growing brain tissue were analyzed.
Methods
Experimental design
Postnatal day 3 (PND 3) SD rats were randomly divided
into 3 experimental groups, which received intraperito-
neal injection of different AlCl3 (Merck 801081) loads
for 14 d: control (normal saline), low Al (LA, 7 mg Al/
kg/d, 1/530 LD50), and high Al (HA, 35 mg Al/kg/d, 1/
106 LD50). The Al content, levels of thiobarbituric acid
reactive substances (TBARS), and activities of super-
oxide dismutase (SOD), catalase, and glutathione perox-
idase (GPx) in the cerebral cortex, hippocampus,
diencephalon, cerebellum, brain stem, pituitary, and ol-
factory bulb were evaluated.
Animals and breeding
Mature Sprague-Dawley (SD) rats were purchased from
the Laboratory Animal Center of National Applied Re-
search Laboratories Taiwan. The processes of protocols
using experimental animals were approved by the Insti-
tutional Animal Care and Use Committee (IACUC) of
Fu-Jen University. All rats were kept individually in
stainless steel cages under a 12/12 h light–dark cycle, at
20°C to 22°C in a 60% humidity animal room. Standard
laboratory chow (Purine Lab. Chow 5001, St. Louis,
MO) and DI water (Millipore, Milli-Q Ultra pure water
system, 18.2 ΩM/cm) were provided ad lib. After 1 wk
adaptation, one male and one female rat were put into
the same cage for mating. The pregnant female rats were
kept individually in plastic cages for approximately 21 d
gestation. Within 24 h of delivery, 10 newborn pups
were placed in a cage with the maternal rat and breast-
fed. Forty-six neonatal pups were divided into the 3 ex-
perimental groups: control (n = 16), LA (n = 16), and HA
(n = 14). Based on the study of Guo et al [18], dosages of
0 (control), 7 (LA), and 35 (HA) mg Al/kg body wt./d
(AlCl3) were intraperitoneally injected into each neo-
natal pup for 14 d.
Sample preparation
Animals were anesthetized and decapitated on PND 17.
The cerebral cortex, hippocampus, diencephalon, cere-
bellum, brain stem, pituitary, and olfactory bulb were
collected. After weighing, a section of each tissue sample
Table 1 Final body weight, body weight gains, the brain
tissues weights (g) of neonatal pups after 2-weeks of
intraperitoneal administration of AlCl3
1,2,3
Control (n = 16) LA (n= 16) HA (n = 14)
(g) (g) (g)
Final body weight 29.9 ± 3.1 28.6 ± 7.7 30.2 ± 5.1
Body weight gains 21.3 ± 1.5 17.9 ± 9.0 20.7 ± 5.2
Whole brain 1.53 ± 0.28 1.29 ± 0.10 1.36 ± 0.14
Cerebral cortex 0.44 ± 0.12 0.37 ± 0.08 0.40 ± 0.09
Hippocampus 0.09 ± 0.03 0.09 ± 0.01 0.10 ± 0.04
Diencephalon 0.44 ± 0.09 0.39 ± 0.06 0.40 ± 0.06
Cerebellum 0.21 ± 0.05 a 0.14 ± 0.03 b 0.14 ± 0.04 b
Brain stem 0.24 ± 0.06 a 0.21 ± 0.03 ab 0.19 ± 0.05 b
Pituitary gland 0.05 ± 0.01 0.04 ± 0.02 0.05 ± 0.02
Olfactory bulb 0.06 ± 0.02 ab 0.04 ± 0.01 b 0.08 ± 0.04 a
1 Values are mean ± SD.
2 Intraperitoneal (IP) administered AlCl3 of 0, 7, 35 mg Al/kg body wt/day for 2
weeks in control, low Al (LA) and high Al (HA) groups respectively.
3 Values in the same raw with different a, b superscripts are significantly
different (p< 0.05).
Table 2 Relative brain tissue weight to body weight ratio
in neonatal pups after 2-weeks intraperitoneal
administration of AlCl3
1,2,3,4
Control (n = 16) LA (n = 16) HA (n = 14)
(%) (%) (%)
Whole brain 5.24 ± 1.51 4.76 ± 1.09 4.66 ± 1.12
Cerebral cortex 1.52 ± 0.53 1.36 ± 0.42 1.36 ± 0.42
Hippocampus 0.30 ± 0.13 0.31 ± 0.07 0.35 ± 0.19
Diencephalon 1.50 ± 0.44 1.47 ± 0.45 1.36 ± 0.29
Cerebellum 0.71 ± 0.24 a 0.53 ± 0.16 ab 0.48 ± 0.18 b
Brain stem 0.83 ± 0.26 0.78 ± 0.21 0.64 ± 0.22
Pituitary gland 0.18 ± 0.05 0.16 ± 0.06 0.18 ± 0.06
Olfactory bulb 0.21 ± 0.09 ab 0.16 ± 0.05 b 0.28 ± 0.15 a
1 Values are mean ± SD.
2 Intraperitoneal (IP) administered AlCl3 of 0, 7, 35 mg Al/kg body wt/day for 2
weeks in control, low Al (LA) and high Al (HA) groups respectively.
3 Values in the same raw with different a, b superscripts are significantly
different (p< 0.05).
4 Relative tissue weight = brain tissue weight (g) / body weight (g) × 100.
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parts were homogenized on ice using various sample
buffers. After centrifugation, supernatants were collected
and frozen at -70°C for oxidative product and anti-
oxidative enzyme analyses.
Determination of Al content
After wet acid digestion of brain tissues, the Al contents
in all samples were determined by using a flameless
atomic absorption spectrophotometer (AAS, 903GBC,
GBC, Australia) with a graphite furnace (System 3000,
GBC, Australia). The instrument was adjusted at a wave-
length of 309.3 nm, with a slit of 0.5 nm and a Hollow
cathode Al lamp (GBC). A lamp current of 8.0 mA, inte-
gration time of 1 s, double beam, and D2 background
correction were used.
Oxidative product and anti-oxidative enzyme assays
The TBARS was measured as the parameter of the lipid
peroxidation of samples according to the protocols
described previously [19]. Lipid peroxides in the sample
by repeat heating with acid would generate the second
product which would react with thiobarbituric acid
(TBA) to form TBARS with the maximal absorbance in
532 nm.
The anti-oxidative enzyme SOD activity was evaluated
using the Cayman Chemical Superoxide Dismutase
Assay Kit (chemical Item Number 706002). O2
˙- and H+
produced by lipids in the sample react with hypoxan-
thine catalyzed by xanthine oxidase to generate the pro-
ducts, H2O2 and O2. The enzyme levels increase with
decreasing of substrate, i.e. O2
˙- [20].
The anti-oxidative enzyme catalase was evaluated
using the Cayman Chemical Catalase Assay Kit (chem-
ical Item Number 707002). Methanol reacts with H2O2
catalyzed by catalase to form formaldehyde. Formaldehyde
and Purpald (4-amino-3-hydrazino- 5-mercapto-1,2,4-
triazole) produce a purple color in which the absorb-
ance at 540 nm is positively correlated with the enzyme
activity [21].
The anti-oxidative enzyme GPx was evaluated using
the Cayman Chemical Glutathione Peroxidase Assay Kit
(chemical Item Number 703102). Oxidized glutathione
(GSSG), produced upon reduction of an organic hydro-
peroxide by GPx, is recycled to its reduced state by GR
and NADPH. The oxidation of NADPH to NADP+ is ac-
companied by a decrease in absorbance at 340 nm. The
rate of decrease in the A340 is directly proportional to
the GPx activity in the sample [22].
Determination of protein level
The protein quantization of each brain tissue was deter-
mined by Pierce CoomassieW Plus Protein Assay Reagent
Kit (chemical Item Number 23236). Basically whenCoomassieW Dye binds protein in an acidic medium, an
immediate shift in absorption maximum occurs from
465 nm to 595 nm with a concomitant color change
from brown to blue [23].Statistical analysis
Data are expressed as mean ± SD and were analyzed
using Statistical Analysis System (SAS), version 9.2.
One-way analysis of variance (ANOVA) was conducted
to detect differences in the measurement values among
groups, followed by Schaffer’s test. Pearson’s correlation
analysis was used to assess the correlation among
Table 3 Al contents in the brain tissues of neonatal pups
after 2-weeks intraperitoneal administration of AlCl3
1,2,3
Control (n = 8) LA (n= 8) HA (n = 7)
Whole brain (ng/g) 165.5 ± 37.9 b 167.4 ± 32.8 b 219.5 ± 43.1 a
Cerebral cortex (ng/g) 60.9 ± 7.5 61.5 ± 26.1 60.4 ± 11.4
Hippocampus (ng/g) 294.9 ± 180.8 b 492.0 ± 236.8 ab 751.0 ± 225.8 a
Diencephalon (ng/g) 20.4 ± 9.6 b 46.9 ± 33.9 b 79.6 ± 20.7 a
Cerebellum (ng/g) 83.1 ± 15.2 b 88.1 ± 21.6 b 144.8 ± 36.2 a
Brain stem (ng/g) 42.0 ± 6.1 41.0 ± 13.0 57.4 ± 21.8
Pituitary gland (mg/g) 3.08 ± 1.42 2.34 ± 0.49 2.42 ± 0.82
Olfactory bulb (ng/g) 173.9 ± 42.2 183.7 ± 36.9 171.2 ± 75.3
1 Values are mean ± SD.
2 Intraperitoneal (IP) administered AlCl3 of 0, 7, 35 mg Al/kg body wt/day for 2
weeks in control, low Al (LA) and high Al (HA) groups respectively.
3 Values in the same raw with different a, b superscripts are significantly
different (p< 0.05).
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Results
Effects of Al on animal growth
Results indicated no significant differences in the body
weight gain among the 3 groups during the experimental
period (p> 0.05). However, the cerebellar weights were
significantly lower in the Al groups than in the control
group (0.14 ± 0.04 (HA), 0.14 ± 0.03 (LA), 0.21 ± 0.05
(control) g; p< 0.05) (Table 1). Similarly, the brain stem
weights were significantly lower in the HA group than
in the control group (0.19 ± 0.05 g v.s. 0.24 ± 0.06 g; p
< 0.05). The weights of the olfactory bulb were signifi-
cantly higher in the HA group than in the LA group
(0.08 ± 0.04 g v.s. 0.04 ± 0.01 g; p< 0.05). The average
cerebellar weight to body weight ratio was significantly
lower in the HA group than in the control group
(0.48 ± 0.18% v.s. 0.71 ± 0.24%; p< 0.05), while the aver-
age olfactory bulb weight to body weight ratio was sig-
nificantly higher in the HA group than in the LA group
(0.28 ± 0.15% v.s. 0.16 ± 0.05%; p< 0.05) (Table 2).Figure 1 TBARS concentrations of brain tissues in neonatal pups afte
(IP) administered AlCl3 of 0, 7, 35 mg Al/kg body wt/day for 2 weeks in con
figure with different A, B superscripts are significantly different (p< 0.05).Aluminum content in different brain tissues
After injection of AlCl3 for 2 wk, the hippocampus
(751.0 ± 225.8 v.s. 294.9 ± 180.8 ng/g; p< 0.05), di-
encephalon (79.6 ± 20.7 v.s. 20.4 ± 9.6 ng/g; p< 0.05),
and cerebellum (144.8 ± 36.2 v.s. 83.1 ± 15.2 ng/g; p
< 0.05) of the HA group displayed significantly higher
Al contents than those of the control group (Table 3). A
similar trend was observed in the brain stem, although
there were no significant differences between the Al-
treated and control groups (57.4 ± 21.8 (HA), 41.0 ± 13.0
(LA), 42.0 ± 6.1 (control) ng/g; p> 0.05). The Al groups
displayed no accumulation of Al in the cerebral cortex,
pituitary, and olfactory bulb when compared with the
control group. Results indicated that the levels of Al in
the diencephalon, hippocampus, cerebellum, and brain
stem of the HA group were 4.0-, 2.5-, 1.7-, and 1.3-fold
respectively, of that in the control group. Aluminum,
thus, more easily aggregated in these 4 regions than in
other tissues in the neonatal brain.Oxidative products in different brain tissues
As shown in Figure 1, the hippocampus displayed higher
levels of lipid peroxide products in the HA group than
in the LA and control groups (35.26 ± 0.88 (HA),
23.67 ± 6.77 (LA), 26.69 ± 1.46 (control) nmol/mL; p
< 0.05). The diencephalon displayed significantly higher
levels of lipid peroxide products in both Al-treated
groups than in the control group (30.08 ± 6.71,
29.64 ± 4.26, 17.55 ± 6.31 nmol/mL; p < 0.05). Lipid per-
oxide product levels were significantly higher in the
cerebellum in the HA group than in the LA and control
groups (31.51 ± 3.48, 21.32 ± 2.23, 21.19 ± 1.33 nmol/mL;
p< 0.05). Similarly, the brain stem lipid peroxide prod-
uct levels were significantly higher in the HA group than
in the LA and control groups (41.98 ± 0.42, 30.49 ± 3.36,
32.29 ± 1.21 nmol/mL; p < 0.05). The levels of lipid per-
oxidative products (TBARS) in the hippocampus, di-
encephalon, cerebellum, and brain stem tissues were,r 2-weeks intraperitoneal administration of AlCl3. Intraperitoneal
trol, low Al (LA) and high Al (HA) groups respectively. Values in the
Figure 2 Specific activities of anti-oxidative enzymes of brain tissues in neonatal pups after 2-weeks intraperitoneal administration of
AlCl3. Intraperitoneal (IP) administered AlCl3 of 0, 7, 35 mg Al/kg body wt/day for 2 weeks in control, low Al (LA) and high Al (HA) groups
respectively. Values in the figure with different A, B superscripts are significantly different (p< 0.05).
Yuan et al. Journal of Biomedical Science 2012, 19:51 Page 5 of 9
http://www.jbiomedsci.com/content/19/1/51thus, significantly higher in the high Al animals com-
pared to the low Al and control animals.Anti-oxidative enzyme activities in different brain areas
The SOD activities in the hippocampus were signifi-
cantly lower in the HA (0.51 ± 0.02 unit/mg protein) and
the LA (0.50 ± 0.01 unit/mg protein) groups compared
to the controls (0.73 ± 0.02 unit/mg protein (Figure 2A)).
So were the cerebellum (0.27 ± 0.06, 0.33 ± 0.02,
0.45 ± 0.04 unit/mg protein; p< 0.05), and brain stem
(0.22 ± 0.02, 0.20 ± 0.03, 0.46 ± 0.05 unit/mg protein;
p< 0.05).
However, catalase activity in the diencephalon was sig-
nificantly higher in the HA group than in the control
group (16.31 ± 2.45 unit/mg protein v.s. 12.86 ± 1.67
unit/mg protein; p< 0.05) (Figure 2B). Conversely, the
catalase activity in the brain stem was significantly lower
in the HA group than in the LA and control groups(15.78 ± 3.88, 25.90 ± 1.38, 23.52 ± 1.93 unit/mg protein;
p< 0.05).
The GPx activities in the hippocampus (44.85 ± 0.79,
21.54 ± 1.02, 18.98 ± 3.15 unit/mg protein; p< 0.05),
cerebellum (31.53 ± 5.79, 23.15 ± 5.29, 24.72 ± 3.16 unit/
mg protein; p< 0.05), and brain stem (38.29 ± 1.98,
15.91 ± 2.62, 13.81 ± 2.69 unit/mg protein; p< 0.05) were
significantly higher in the HA group than in the LA and
control groups (Figure 2C).
The correlations among aluminum, oxidative products,
and anti-oxidative enzyme activities
The result of correlation analysis indicated that there
was a positive correlation between aluminum contents
and TBARS in the hippocampus, cerebellum, and brain
stem (r = 0.34, p= 0.08; r = 0.69, p< 0.05; r = 0.45, p
< 0.05). Meanwhile, there was a positive correlation be-
tween aluminum contents and GPx (r = 0.56, p< 0.05;
r = 0.55, p< 0.05; r = 0.49, p< 0.05), but a negative
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(r = -0.53, p< 0.05; r = -0.57, p< 0.05; r = -0.18, p= 0.37)
in the hippocampus, cerebellum, and brain stem. On the
other hand, a positive correlation existed between
aluminum contents and catalase in the diencephalon
(r = 0.56, p< 0.05), while there was a negative correlation
in the brain stem (r = -0.47, p< 0.05).
Discussion
The initial objective of present study was to evaluate the
accumulation of Al in the brains of neonates receiving
high Al-containing commercial infant formula. However,
it was not possible to conduct the analyses on human
newborns. Three-week-old rats were, therefore, used to
imitate 6-month-old infants during the breastfeeding
period. Although previous studies have suggested that
excess Al accumulates in the hippocampus, dienceph-
alon, and cerebellum, no prior investigation has reported
Al oxidative damage in various areas of the brain in neo-
natal rats. The present study’s results suggest that toxic
Al concentrations, and oxidative damage caused by Al,
occur in the 4 functional areas of the hippocampus, di-
encephalon, cerebellum, and brain stem in growing brain
tissue.
The pathological toxic concentration of Al in
neonatal brain
The results of present study showed that the Al concen-
tration in the whole brain of neonatal rats (PND 17)
were 165.5 ng/g, 167.4 ng/g, and 219.5 ng/g which are
much lower than the Al concentrations from our previ-
ous pilot work, 790 ng/g, 830 ng/g, and 1440 ng/g re-
spectively when neonates were fed artificial rats milk at
the dosage of 0, 22.5 and 225 mM AlCl3 respectively
from PND 3 to 17). In addition, the levels of Al in the
diencephalon, hippocampus, and cerebellum, were 1.5–8
fold higher respectively, in the gastrostomy bolus feeding
groups (440.0 ± 20.0 (HA) ng/g, 1180.0 ± 30.0 (HA),
1100.0 ± 60.0 (HA) ng/g) than that in the present work
(79.6 ± 20.7 (HA) ng/g, 751.0 ± 225.8 (HA), 144.8 ± 36.2
(HA) ng/g). It is suggested that Al levels in neonatal
whole brain and/or various functional brain areas
through the intraperitoneal injection would not exceed
the physiological concentrations of Al from formula gas-
trostomy bolus feeding.
The distribution of Al in neonatal rat brain
When evaluating the effects of high Al on brain growth,
the results indicated marginal changes in tissue weights
in the cerebral cortex, pituitary, and olfactory bulb, as
illustrated in Tables 1 and 2. However, no previous study
has reported weight changes in these brain areas. Evalua-
tions of Al distribution revealed that Al predominantly
accumulated in the hippocampus, diencephalon(including the thalamus, metathalamus, hypothalamus,
epithalamus, prethalamus or subthalamus, and pretec-
tum), cerebellum, and brain stem (including the medulla
oblongata, pons, and midbrain) of neonatal rats. Previ-
ous studies on adult rats have described Al accumulation
in the same brain areas. Gomez and colleagues observed
high levels of Al in the cortex, hippocampus, and cere-
bellum [24] of Aβ PP transgenic mice provided 1 mg Al/
g feed for 6 mo. Domingo and colleagues further
described Al in the cortex, thalamus, and olfactory bulb
in rats [25] following administration of Al at doses of 0,
50, and 100 mg Al (Al nitrate)/kg body wt/d in drinking
water over 6.5 mo. Sanchez-Iglesias et al have also iden-
tified Al accumulation in the cortex, hippocampus, stri-
atum, cerebellum, and ventral midbrain of rats following
treatment with intraperitoneal injected or orally drinking
with aluminum chloride [26]. The results of the present
study indicated that administration of high concentra-
tion AlCl3 induced higher levels of Al accumulation in
the brain stem. Consistent with previous studies on
adult rats, distribution of Al mainly occurred in 3 spe-
cific areas in neonatal rat brain: the hippocampus, di-
encephalon, and cerebellum. Higher accumulation of Al
also occurred in these brain regions in the neonatal rats.
Results indicated limited deposition of Al in the cerebral
cortex, pituitary, and olfactory bulb.
Effects of Al on the production of oxidative products in
the hippocampus, diencephalon, cerebellum,
and brain stem
The hippocampus, diencephalon, cerebellum, and brain
stem tissues of high Al animals displayed significant
increases in the levels of lipid peroxidative products
(TBARS). Previous research, which involved oral admin-
istration of Al (0.1 mmol/kg/d) [27,28] or intraperitoneal
injection of Al (7 mg/kg/d) for 11 wk [29], also sug-
gested that high accumulation of Al in the hippocampus
increased the lipid peroxidative products. Similarly,
Nehru and Bhalla reported elevated Al in the dienceph-
alon of female Sprague Dawley rats administered with
AlCl3 (40 mg/ kg/d) for 8 wk, accompanied by increased
lipid peroxidation in the hypothalamus (part of the di-
encephalon) [30]. Several other studies have shown that
accumulation of Al in the cerebellum increased the lipid
peroxidative products. In one study, oral administration
of Al (100 mg/kg/d) for 2 mo increased lipid peroxida-
tion in the cerebellum of adult rats [31]. The cerebellar
TBARS levels also increased in rats intraperitoneally
injected with aluminum lactate (7 mg Al/kg/d) for 11 wk
[32]. Nehru et al further identified significant increases
in lipid peroxidation in the cerebrum and cerebellum of
pup brains following exposure of developed and devel-
oping rat brains to oral aluminum chloride (100 mg/kg/
d) for 6 wk or 8 wk [33]. Investigations on the brain
Figure 3 Diagrammatic representation of the relation among the aluminum (gray), reactive oxygen species (yellow), anti-oxidative
enzymes (pink) and lipid peroxidation. TBARS= thiobarbituric acid reactive substances; SOD= superoxidase dismutase; GPx = glutathione
peroxidase. (It is adapted from the research findings of Exley, 2004; Halliwell and Gutteridge, 2007).
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tion in the medulla oblongata [30,34] and ventral mid-
brain [35] of adult rats. Results, therefore, suggest that
increased lipid peroxidation in the brain stem was asso-
ciated with high Al.
Two animal studies with high level of intraperitoneal
injection of Al (7 mg/kg/d) for 11 wk [29], and oral Al
intakes 100 mg/kg/d for 2 mo [31], resulting in high Al
contents, 22.26 ± 12.7 μg/g in the hippocampus and
640 ± 50 μg/g in the cerebellum respectively. Both
showed the increase of oxidative products in the brain
tissues. However, much lower Al concentrations in the
hippocampus (751.0 ± 225.8 ng/g) and the cerebellum
(144.8 ± 36.2 ng/g) could also induce the lipid peroxida-
tion in the brain of the neonatal rat in our study. There-
fore, it is quite possible to induce lipid per-oxidation of
brain tissues in the neonatal animals even a slightly but
significant increase of Al.
Effects of Al on the activities of anti-oxidative enzymes in
the hippocampus, diencephalon, cerebellum,
and brain stem
The present study’s analyses comfirmed that high Al
could induce oxidative stress and cause lipid peroxida-
tion in the hippocampus, diencephalon, cerebellum, and
brain stem. In these tissues, the initiation of antioxida-
tive enzymes to oppose the oxidative stress was
expected. Study findings revealed that the activities of
SOD decreased with increasing lipid peroxidation in the
hippocampus, cerebellum, and brain stem tissues of high
Al animals. This was consistent with several otherstudies which identified significantly decreased SOD activ-
ities in the hippocampal region [28,35], cerebellum [33-
35], and brain stem [34,35] in high Al animals. However,
none of these four studies have measured the final Al con-
centration of brain tissues, although all had Al-overload
through various routes, i.e. drinking water, intra-peritoneal,
or oral gavage.
In our present study, the HA group displayed
increased catalase activity in the diencephalon. The
study of Nehru and Bhalla, however, described decreased
catalase activity in the hypothalamus (part of the di-
encephalon) of high Al-treated rats [30]. The discrep-
ancy of catalase activities between our study and this
study might be due to the Al levels in the diencephalon.
Unfortunately, no data of Al content was reported in
Nehru and Bhalla’ report. Nevertheless, it is believed that
the regulation of catalase gene transcription is
responded to modification of cellular redox levels. Spie-
gelman’s study had reviewed that the role of PGC1 tran-
scription coactivators are induced when cells are given
ROS. PGC1 includes genes encoding proteins like SOD,
catalase, and GPx [36]. Activated OxyR transcription fac-
tor switches on several genes encoding antioxidant func-
tions, such as catalase, reported in Dample’s study [37].
In the present study, GPx activity was significantly
higher in the cerebellum, hippocampus, and brain stem
in the HA group than in the other two groups. Similar
results were reported by Esparza et al [32]. On the other
hand, opposing results were shown in the hippocampus
and brain stem following Al treatment [28,35]. Again,
these studies also displayed with no data of the final Al
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http://www.jbiomedsci.com/content/19/1/51concentration in brain tissue, even with Al-overload by
drinking water or intraperitoneally injection.Aluminum causes oxidative stress in neonatal brain
through production of ROS free radicals
The present study identified that Al induced produc-
tion of the ROS free radical H2O2, which participated
in oxidative stress in neonatal brain. Figure 3 proposed
a theoretical diagram of the relationship between
aluminum, ROS, anti-oxidative enzymes, and lipid per-
oxidation. It is adapted from the research findings of
Exley, Halliwell, and Gutteridge [4,38], which suggested
Al involved in the iron Fenton reaction in the brain.
In this reaction, Al3+ (gray), Fe2+, and unpaired elec-
trons mediate the production of ROS such as O2
˙-,
H2O2, OH
˙, OH-, and AlO2
˙- (yellow). Superoxide dis-
mutase activity indicated the production of O2
˙-, cata-
lase and GPx activities confirmed the production of
H2O2 and OH
˙ (anti-oxidative enzymes; pink). Nega-
tively charged phospholipids of brain cell membranes,
which contain polyunsaturated fatty acids, are easily
attacked by ROS [4,39,40]. The present study used
TBARS to represent peroxidative damage to phospholi-
pids on cell membranes caused by Al. Results of sig-
nificantly modified oxidative enzymes by Al deposition
in neonatal brain tissues confirmed high H2O2 produc-
tion in high Al brain. The increased H2O2 might in-
duce peroxidization in a higher proportion of
phospholipids to increase TBARS values. In the present
work, the correlation analyses also confirmed the the-
ory. This suggested that oxidative stress caused by high
Al content is greater than the protection provided by
the anti-oxidizing system; subsequently leading to high
possibility of oxidative damage to brain tissue. Esparza
et al reported that Al concentration in the brain tissue
increased with increasing Al intake, but not in a dose-
dependent manner. Oxidative damage occurred in spe-
cific brain areas of adult rats [32].Conclusions
The results of the present study demonstrate that ex-
cess Al accumulates in specific areas of the brain, in-
cluding the hippocampus, diencephalon, cerebellum,
and brain stem in neonatal rats following intraperito-
neal injection of high levels of Al. High Al signifi-
cantly decreased the activities of SOD, but increased
the activities of GPx and TBARS level in these spe-
cific brain regions. High Al accumulation might induce
H2O2 production. The intraperitoneal administration
of 35 mg Al/kg body wt/d, therefore, increased oxida-
tive stress in four specific brain areas in neonatal
rats. These findings suggest a possible molecular
mechanism for Al-induced oxidative damage inhippocampal and other brain cells. Further investiga-
tion of this mechanism, including behavioral analyses,
is warranted.
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